| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 10/19/2006 | US20060234349 Fungal cell wall synthesis gene |
| 10/19/2006 | US20060234283 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity |
| 10/18/2006 | CN1849117A Entry inhibitors of the HIV virus |
| 10/17/2006 | US7122673 Cyclization of imines to form compounds such as 4-Phenyl-6H-(1)Benzopyrano(4',3':4,5)pyrrolo(2,1-a)isoquinolin-6-one, used as nontoxic modulators of multidrug resistant cells; antitumor agents |
| 10/17/2006 | US7122672 N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; treating agricultural and horticultural fungal infections of plants |
| 10/17/2006 | US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 10/17/2006 | US7122559 Useful as anticoagulants in therapy and prophylaxis of cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in therapy of cancer |
| 10/17/2006 | CA2275686C Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors |
| 10/17/2006 | CA2197207C Hiv protease inhibitor combination |
| 10/12/2006 | WO2006108107A1 Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors |
| 10/12/2006 | WO2006061217A3 Saquinavir derivatives useful in immunoassay |
| 10/12/2006 | WO2006060225A3 Process for asymmetric synthesis of hexahydropyrimido[1,2-a] azepine-2-carboxamides and related compounds |
| 10/12/2006 | WO2006020049A3 Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 10/12/2006 | US20060229333 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 10/12/2006 | CA2603250A1 Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors |
| 10/11/2006 | EP1710238A1 Benzophenones as inhibitors of reverse transcriptase |
| 10/11/2006 | EP1708999A1 Bronchorelaxing compounds |
| 10/11/2006 | EP1708994A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 10/11/2006 | EP1708698A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 10/11/2006 | EP1469851B1 Melanocortin receptor agonists |
| 10/11/2006 | EP1216232B1 Heterocyclic compounds and methods for modulating cxcr3 function |
| 10/11/2006 | CN1845740A Piperazine derivatives for the treatment of HIV infections |
| 10/10/2006 | US7119103 β3-Adrenoreceptor agonists, agonist compositions and methods of using |
| 10/10/2006 | CA2253407C Inorganic ion receptor-active compounds |
| 10/05/2006 | WO2006105127A2 Hydroxysteroid dehydrogenase inhibitors |
| 10/05/2006 | WO2006104141A1 3-propenylcephem derivative |
| 10/05/2006 | WO2006102998A1 Substituted tetrahydroisochinolines as mmp inhibitors, related production method and use as medicine |
| 10/05/2006 | WO2006102760A1 Inhibitors of histone deacetylase |
| 10/05/2006 | WO2005115392A8 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors |
| 10/05/2006 | WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators |
| 10/05/2006 | US20060223847 Anti-coronavirus drug |
| 10/05/2006 | US20060220004 with Tris(2-bromo-6-pyridyl)phosphine oxide ligands; organic light-emitting diodes, integrated circuits, organic field-effect transistors, thin-film transistors, organic solar cells, and/or laser diodes |
| 10/05/2006 | DE102005015040A1 Substituierte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted tetrahydroisoquinolines as MMP inhibitors, to processes for their preparation and their use as a medicament |
| 10/05/2006 | CA2603589A1 Inhibitors of histone deacetylase |
| 10/05/2006 | CA2603345A1 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents |
| 10/04/2006 | EP1372653B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 10/04/2006 | EP0906091B1 Amidinohydrazones as protease inhibitors |
| 10/03/2006 | US7115743 For treatment of leukemia, carcinomas, adenocarcinomas, and melanoma; assaying metabolism via cytochromes |
| 10/03/2006 | US7115664 Peptidomimetic ligands for cellular receptors and ion channels |
| 10/03/2006 | US7115652 Aspartyl protease inhibitors |
| 10/03/2006 | US7115646 Cyclic diamines and derivatives as factor Xa inhibitors |
| 10/03/2006 | US7115607 Substituted piperazinyl amides and methods of use |
| 10/03/2006 | US7115605 Peptide deformylase inhibitors |
| 10/03/2006 | US7115600 Histamine-3 receptor modulators |
| 09/28/2006 | WO2006100100A1 Tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents |
| 09/28/2006 | US20060217416 Antihypoxic agents; adjust concentration of erythropoietin concentration in blood; strokes; antiepileptic agents; neurodegenerative disease ; liver disorders; antiischemic agents |
| 09/28/2006 | US20060217384 e.g. 1-((3-Phenyl-1,2,4-triazolo(3,4-a)phthalazines-6-yl)carbonyl)piperidine; high affinity to the benzodiazepine site of GABAA receptors; central nervous system (CNS) diseases such as depression, anxiety, and attention deficit disorder |
| 09/28/2006 | US20060217372 Diaryl ethers as opioid receptor antagonist |
| 09/28/2006 | CA2598205A1 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 09/27/2006 | EP1704856A1 Hsp90 family protein inhibitor |
| 09/27/2006 | EP1286967B1 Cyclohexane derivatives and their use as therapeutic agents |
| 09/26/2006 | US7112586 Substituted diamine derivatives useful as motilin antagonists |
| 09/21/2006 | WO2006099060A2 Process for the preparation of opioid modulators |
| 09/21/2006 | WO2006098982A1 Process for the preparation of opioid modulators |
| 09/21/2006 | WO2006098855A2 Processes for preparing morphinans and intermediates thereof |
| 09/21/2006 | WO2006098308A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | WO2006097323A1 TETRAHYDRO-ISOQUINOLIN-l-ONES FOR THE TREATMENT OF CANCER |
| 09/21/2006 | WO2006067587A3 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| 09/21/2006 | WO2006063294A3 Novel inhibitors of histone deacetylase for the treatment of disease |
| 09/21/2006 | US20060211863 Process for the preparation of opioid modulators |
| 09/21/2006 | US20060211675 Preventives/remedies for urinary disturbance |
| 09/21/2006 | US20060211590 Organic catalyst with enhanced solubility |
| 09/21/2006 | US20060211107 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 09/21/2006 | CA2602609A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | CA2601674A1 Process for the preparation of opioid modulators |
| 09/21/2006 | CA2601481A1 Process for the preparation of opioid modulators |
| 09/21/2006 | CA2600687A1 Processes for preparing morphinans and intermediates thereof |
| 09/20/2006 | EP1701724A2 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
| 09/20/2006 | EP1611106B1 Preparation of quinapril hydrochloride |
| 09/20/2006 | EP1392363B1 Use of mGLuR5 antagonists in the manufacture of a medicament in the treatment of Fragile X syndrome, Autism and Mental Retardation |
| 09/20/2006 | CN1835924A Fused compounds that inhibit vanilloid receptor subtype 1(vr1) receptor |
| 09/20/2006 | CN1275944C Process for preparing (s)-6,7-dimethoxy-1,2,3,4-tetrahydro isoquinoline-3-carboxylic acid |
| 09/19/2006 | US7109224 Acyl guanidine compounds and use thereof |
| 09/19/2006 | US7109212 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 09/14/2006 | WO2006095922A1 Tetrahydroisoquinoline compound and medicinal use thereof |
| 09/14/2006 | US20060205772 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type I |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | CN1832925A New p2x7 receptor avtagonists and their use |
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/12/2006 | US7105702 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation |
| 09/12/2006 | US7105701 Multibinding compounds for agonists for phenolic derivatives for adrenergic receptors with carriers |
| 09/12/2006 | US7105538 4-oxo-4-[2-(5-pyridin-4-yl-[1,3,4]oxadiazol-2-yl)-pyrrolidin-1-yl]-butyric acid ethyl ester; inhibition of serotonin re-uptake; analgesic effect |
| 09/12/2006 | US7105536 Compounds |
| 09/12/2006 | US7105507 Cyclohexane derivatives and their use as therapeutic agents |
| 09/12/2006 | CA2241788C Novel n-(arylsulphonyl)amino acid derivatives, their preparation process and pharmaceutical compositions containing them |
| 09/08/2006 | WO2006093823A1 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
| 09/08/2006 | WO2005117907A3 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions |
| 09/08/2006 | CA2599808A1 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
| 09/07/2006 | US20060199826 Cyclopropane compounds and pharmaceutical use thereof |
| 09/06/2006 | EP1697304A1 Peroxisome proliferator activated receptor modulators |
| 09/05/2006 | US7101892 2-(4-benzenesulfonyl-4-methyl-pentyl)-5-phenyl-2-aza-bicyclo[2.2.1]heptane; useful for treating sleep disorder, depression, anxiety |
| 09/05/2006 | US7101881 N-(4-Chlorophenylacetyl)-8-(4-methylpiperazinyl)-tetrahydroisoquinoline; treating anxiety, depression, dysthymia, major depressive disorder, migraine, post-traumatic stress disorder, avoidant personality disorder, borderline personality disorder, phobias |
| 08/31/2006 | WO2006090783A1 Process for production of 4-fluoroisoquinoline-5-sulfonyl halide or salt thereof |
| 08/31/2006 | WO2006074223A3 Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof |
| 08/31/2006 | WO2005080313A9 Sulfonamide derivatives for the treatment of diseases |
| 08/31/2006 | US20060194798 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 08/30/2006 | EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1694329A2 Diamine and iminodiacetic acid hydroxamic acid derivates |
| 08/30/2006 | EP1318811B1 Cyclopentyl modulators of chemokine receptor activity |
| 08/30/2006 | CN1826115A Substituted piperidine compounds and methods of their use |